Trial Profile
The effects of atorvastatin on the Rho/Rho kinase pathway in patients with atherosclerosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 29 Oct 2005 New trial record.